Xilio Therapeutics, Inc.
XLO
$0.6957
-$0.0041-0.59%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 36.46% | 61.10% | -9.74% | -18.27% | 120.57% |
Total Receivables | -- | 0.00% | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1.79% | -27.73% | 43.56% | -32.98% | -41.23% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 32.74% | 54.73% | -4.86% | -18.84% | 12.75% |
|
|||||
Total Current Assets | 32.74% | 54.73% | -4.86% | -18.84% | 12.75% |
Net Property, Plant & Equipment | -4.87% | -3.65% | -5.38% | -4.30% | -5.09% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.34% | 0.34% | 0.39% | -4.62% | -35.47% |
Total Assets | 29.02% | 45.92% | -4.80% | -16.93% | 8.79% |
|
|||||
Total Accounts Payable | 80.09% | -11.62% | 164.81% | -23.10% | 69.44% |
Total Accrued Expenses | 44.76% | -61.10% | 1.92% | 0.58% | 21.68% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 3.10% | 3.20% | 3.13% | 2.58% | 1.26% |
Total Finance Division Other Current Liabilities | 5.03% | 197.77% | -48.22% | -1.55% | 22.06% |
Total Other Current Liabilities | 5.03% | 197.77% | -48.22% | -1.55% | 22.06% |
Total Current Liabilities | 11.80% | 74.74% | -28.30% | -1.60% | 22.35% |
|
|||||
Total Current Liabilities | 11.80% | 74.74% | -28.30% | -1.60% | 22.35% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -5.06% | -4.54% | -4.25% | -4.00% | -3.78% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 73.41% | 101.13% | 129.34% | -18.06% | -41.09% |
Total Liabilities | 36.26% | 73.94% | -0.39% | -4.91% | -0.68% |
|
|||||
Common Stock & APIC | 3.00% | 1.59% | 2.48% | 0.40% | 5.86% |
Retained Earnings | -3.99% | -3.46% | -3.53% | -3.93% | -4.06% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -33.93% | -39.20% | -16.10% | -37.23% | 29.70% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -33.93% | -39.20% | -16.10% | -37.23% | 29.70% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -33.93% | -39.20% | -16.10% | -37.23% | 29.70% |
|